ValuEngine downgraded shares of Senesco Technologies Inc. (OTCMKTS:SVON) from a hold rating to a sell rating in a research report sent to investors on Monday.

Shares of Senesco Technologies (OTCMKTS SVON) opened at 0.2164 on Monday. Senesco Technologies has a 12 month low of $0.08 and a 12 month high of $0.38. The company’s 50-day moving average is $0.27 and its 200-day moving average is $0.25. The firm’s market cap is $5.83 million.

ILLEGAL ACTIVITY WARNING: “ValuEngine Lowers Senesco Technologies Inc. (SVON) to Sell” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at

About Senesco Technologies

Sevion Therapeutics, Inc is a development-stage biotech company. The Company is engaged in building and developing a portfolio of therapeutics, from both internal discovery and acquisition, for the treatment of cancer and immunological diseases. The Company is engaged in the development and licensing of technology to discover and engineer monoclonal antibodies.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Stock Ratings for Senesco Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senesco Technologies Inc. and related stocks with our FREE daily email newsletter.